Description

Important information, uses, advantages and safety of Trastuzumab 150mg

Trastuzumab 150mg is a targeted cancer medicine, containing trastuzumab, a humanised monoclonal antibody. It works by targeting HER2, a protein that can be expressed at high levels on some cancer cells. Trastuzumab binds to HER2, so it blocks the growth signals and helps the immune system to attack the HER2-positive cancer cells.

The 150 mg strength is often provided as a vial of trastuzumab powder for reconstitution by health care professionals for intravenous infusion. For example, Herceptin 150 mg was identified as a powder for concentrate for solution for infusion by the European Medicines Agency, with each vial containing 150 mg of trastuzumab.

What is Trastuzumab 150mg Injection?

Trastuzumab 150mg is a type of medicine known as a targeted therapy. Traditional chemotherapy can affect many cells that are dividing quickly, whereas trastuzumab specifically targets the HER2 pathway. That’s why doctors use it when lab tests show a cancer is HER2-positive.

Trastuzumab is indicated for the treatment of certain breast cancers and in selected patients with stomach cancer and cancer of the gastrooesophageal junction. The approved uses may vary depending on the product, country, stage of cancer and combination of treatments.

Trastuzumab Mechanism of Action: How Does It Work?

HER2 is a receptor that is part of the signals that tell cells to grow. Some cancers have too much of a protein called HER2, which can help the cancer cells to grow. Trastuzumab binds to the HER2 on cancer cells. This, in turn, interrupts HER2 signalling and initiates an immune response against cells with high expression of HER2.

Trastuzumab may be used by doctors to treat certain HER2-positive cancers because it works on a specific target . It can be used alone or in combination with other anticancer medicines depending on the individual treatment plan.

What is Trastuzumab 150mg prescribed for?

Some breast cancers have lots of HER2 on the surface of their cells . These may be treated with medicines that have trastuzumab in them . The treatment is given preoperatively, postoperatively or for metastatic disease, depending on the clinical setting. It may also be used for the treatment of selected patients with HER2-positive cancer of the stomach or gastrooesophageal junction.

But trastuzumab is not right for all cancer patients. Testing the tumour for HER2 is critical since the drug is designed for cancers that have the target.

How do you administer Trastuzumab 150mg?

Trastuzumab 150mg is neither a standard tablet nor a normal oral medicine. The 150 mg presentation of Herceptin is a powder that is reconstituted by healthcare professionals for intravenous infusion. Treatment should therefore be carried out under suitable medical supervision.

The treatment schedule depends on the type of cancer, the combination of treatments, previous therapy and the specific trastuzumab product. Some regimens involve weekly administration and others an interval of three weeks. The treatment is calculated and adapted according to the approved regimen and the clinical needs of the patient.

Therefore, the patients should not self-determine the dose and frequency of trastuzumab.

Side effects Common

Like all medicines, Trastuzumab 150mg can cause side effects, but not everyone gets them. Some patients may experience infusion-related symptoms, fatigue, fever, chills, nausea, diarrhoea, headache or other effects related to the treatment.

But more importantly, trastuzumab can cause serious heart problems, such as decreased heart function or heart failure. It can also cause serious infusion reactions and, more rarely, serious lung-related complications. Medical teams therefore closely monitor patients during treatment.

If you develop new shortness of breath, swelling, symptoms in your chest, extreme weakness, or other concerning changes, call your healthcare team immediately.

“Heart Monitoring During Treatment”

Monitoring of heart function is an important part of trastuzumab therapy. Trastuzumab may have effects on the heart in some patients, so healthcare professionals might monitor heart function before and during therapy. Certain treatment combinations carry a higher risk, especially those that include anthracycline medications.

Patients should therefore tell their doctor if they have a history of heart problems and make sure they attend all recommended monitoring appointments.

Important Safety Information

Trastuzumab is a medicine that needs specialist doctor supervision. Patients must provide their full medical history and tell their healthcare provider about other medications and cancer therapies they are taking.

Special care is also required in pregnancy. Trastuzumab may cause harm to the foetus. Women who have the potential to become pregnant should discuss with their healthcare professional their plans for pregnancy prevention and treatment.

The healthcare team may also monitor for infusion reactions and breathing problems while you are receiving treatment. “Severe symptoms require immediate medical attention.”

Questions & Answers

Is Trastuzumab 150mg chemotherapy?

Trastuzumab is a monoclonal antibody (a targeted therapy), not a conventional chemotherapy. But doctors may use it with chemotherapy or other cancer drugs as part of a broader treatment plan.

What is 150mg?

150mg refers to the amount of trastuzumab in the vial presentation. Normal dosing doesn’t mean everyone is getting the full dose of 150mg. Treatment is tailored and prescribed by a qualified oncology team. Herceptin 150mg is listed by the EMA as being contained in a single vial containing 150mg of trastuzumab.

Yes, Trastuzumab 150mg is used for HER2 positive cancer.

Yes. Trastuzumab is targeted specifically to HER2 and is approved for certain HER2 positive breast cancers and some other HER2 positive cancers.

Is Trastuzumab 150mg taken by mouth?

No Herceptin 150mg presentation is for intravenous infusion only and not for oral use.

Is monitoring required for trastuzumab?

Yes. Medical monitoring is important because trastuzumab can cause infusion reactions and impact on heart function.

Final thought

Trastuzumab 150mg is a key drug targeting HER2 receptor in some cancer treatment regimens. It targets the HER2 protein, so appropriate tumour testing is needed first, and then the most appropriate regimen for each patient can be selected. Moreover, the drug requires professional preparation, intravenous administration and continuous safety monitoring.